The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(1-(3-(indolin-1-yl)propyl)piperidin-4-yl)-1H-indole ID: ALA3609356
PubChem CID: 9820229
Max Phase: Preclinical
Molecular Formula: C24H29N3
Molecular Weight: 359.52
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc2c(c1)CCN2CCCN1CCC(c2c[nH]c3ccccc23)CC1
Standard InChI: InChI=1S/C24H29N3/c1-4-9-24-20(6-1)12-17-27(24)14-5-13-26-15-10-19(11-16-26)22-18-25-23-8-3-2-7-21(22)23/h1-4,6-9,18-19,25H,5,10-17H2
Standard InChI Key: MFDYWYJOGOJHIF-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1749 2.6315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2517 3.8078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8114 5.1995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2965 5.4106 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2218 4.2301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6621 2.8384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8593 6.8019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3455 7.0110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9084 8.4023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3946 8.6114 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3891 7.5382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7452 8.1856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5459 9.6655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0740 9.9277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5472 11.3364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5313 12.4945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0031 12.2323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5268 10.8056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 1 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
9 10 1 0
13 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 23 1 0
21 20 1 0
20 19 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.52Molecular Weight (Monoisotopic): 359.2361AlogP: 4.80#Rotatable Bonds: 5Polar Surface Area: 22.27Molecular Species: BASEHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.43CX LogP: 4.57CX LogD: 2.55Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.71Np Likeness Score: -0.92
References 1. Hayashi R, Ohmori E, Moriwaki M, Kumagai H, Isogaya M.. (2015) Indolylpiperidine derivatives as potent and selective α1B adrenoceptor antagonists., 25 (18): [PMID:26238322 ] [10.1016/j.bmcl.2015.07.046 ]